What is Accuray?
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. Accuray's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally, supporting treatment of various cancer types across different anatomical sites.
How much funding has Accuray raised?
Accuray has raised a total of $500M across 5 funding rounds:
Stock Offering
$288M
Debt
$70M
Debt
$52M
Debt
$40M
Debt
$50M
Stock Issuance/Offering (2007): $288M, investors not publicly disclosed
Debt (2016): $70M led by Cerberus Business Finance, LLC
Debt (2017): $52M supported by MidCap Financial Trust
Debt (2017): $40M featuring MidCap Financial Trust
Debt (2025): $50M backed by Wingspire Capital
Key Investors in Accuray
Wingspire Capital
Wingspire Capital is a diversified specialty finance firm that provides innovative, one-stop financing solutions for middle-market companies, offering customized senior loans and combining revolving lines of credit and secured term loans.
MidCap Financial Trust
MidCap Financial Trust is a financial entity that has provided debt financing to Accuray, indicating a role in supporting the company's operational and growth capital needs.
Cerberus Business Finance, LLC
Cerberus Business Finance, LLC, part of Cerberus Capital Management, is a provider of financing solutions, having previously extended debt to Accuray, supporting its strategic financial objectives.
What's next for Accuray?
With a major enterprise-level funding context and a recent strategic investment, Accuray is poised for significant advancements in its mission to enhance cancer care. This backing is expected to fuel further innovation in their precision radiation oncology systems, potentially expanding market reach and accelerating the development of next-generation treatment technologies. The company's focus on integrating sophisticated imaging and adaptive planning suggests a strategic direction towards more personalized and effective cancer therapies, aiming to improve patient outcomes and quality of life globally.
See full Accuray company page
